Ignite Creation Date:
2025-12-24 @ 2:22 PM
Ignite Modification Date:
2026-01-05 @ 4:50 PM
Study NCT ID:
NCT06829459
Status:
RECRUITING
Last Update Posted:
2025-04-08
First Post:
2025-02-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIs
Sponsor:
Shanghai JMT-Bio Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-03
Start Date Type:
ACTUAL
Primary Completion Date:
2028-02-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-02-15
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-11
First Submit QC Date:
None
Study First Post Date:
2025-02-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-06
Last Update Post Date:
2025-04-08
Last Update Post Date Type:
ACTUAL